Annual CFO
-$14.68 M
-$43.10 K-0.29%
June 1, 2024
Summary
- As of February 24, 2025, NEUP annual cash flow from operations is -$14.68 million, with the most recent change of -$43.10 thousand (-0.29%) on June 1, 2024.
- During the last 3 years, NEUP annual CFO has fallen by -$9.02 million (-159.19%).
Performance
NEUP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$3.36 M
+$1.07 M+24.25%
December 1, 2024
Summary
- As of February 24, 2025, NEUP quarterly cash flow from operations is -$3.36 million, with the most recent change of +$1.07 million (+24.25%) on December 1, 2024.
- Over the past year, NEUP quarterly CFO has stayed the same.
Performance
NEUP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$7.79 M
+$587.00 K+7.01%
December 1, 2024
Summary
- As of February 24, 2025, NEUP TTM cash flow from operations is -$7.79 million, with the most recent change of +$587.00 thousand (+7.01%) on December 1, 2024.
- Over the past year, NEUP TTM CFO has stayed the same.
Performance
NEUP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NEUP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.3% | 0.0% | 0.0% |
| 3 y3 years | -159.2% | +24.2% | -75.9% |
| 5 y5 years | - | - | - |
NEUP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +159.2% | +1.9% | at high | +32.0% | +75.9% | +7.5% |
| 5 y | 5-year | +447.4% | +1.9% | at high | +32.0% | +75.9% | +7.5% |
| alltime | all time | +447.4% | +1.9% | at high | +32.0% | +75.9% | +7.5% |
Neuphoria Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$3.36 M(-24.2%) | -$7.79 M(-7.0%) |
| Sep 2024 | - | -$4.43 M(+12.4%) | -$8.38 M(+0.0%) |
| Jun 2024 | -$14.68 M | - | - |
| Dec 2023 | - | -$3.95 M(-10.9%) | -$8.37 M(+89.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$4.43 M | -$4.43 M |
| Jun 2023 | -$14.64 M(-2.2%) | - | - |
| Jun 2022 | -$14.97 M(+164.2%) | - | - |
| Jun 2021 | -$5.66 M(+111.2%) | - | - |
| Jun 2020 | -$2.68 M | - | - |
FAQ
- What is Neuphoria Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual CFO year-on-year change?
- What is Neuphoria Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly CFO year-on-year change?
- What is Neuphoria Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics TTM CFO year-on-year change?
What is Neuphoria Therapeutics annual cash flow from operations?
The current annual CFO of NEUP is -$14.68 M
What is the all time high annual CFO for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual cash flow from operations is -$2.68 M
What is Neuphoria Therapeutics annual CFO year-on-year change?
Over the past year, NEUP annual cash flow from operations has changed by -$43.10 K (-0.29%)
What is Neuphoria Therapeutics quarterly cash flow from operations?
The current quarterly CFO of NEUP is -$3.36 M
What is the all time high quarterly CFO for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly cash flow from operations is -$3.36 M
What is Neuphoria Therapeutics quarterly CFO year-on-year change?
Over the past year, NEUP quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Neuphoria Therapeutics TTM cash flow from operations?
The current TTM CFO of NEUP is -$7.79 M
What is the all time high TTM CFO for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high TTM cash flow from operations is -$4.43 M
What is Neuphoria Therapeutics TTM CFO year-on-year change?
Over the past year, NEUP TTM cash flow from operations has changed by $0.00 (0.00%)